Regenxbio Inc. (RGNX) Q4 2020 Earnings Call Transcript

Motley Fool Transcribers, The Motley Fool
·29 min read
Regenxbio Inc. (RGNX) Q4 2020 Earnings Call Transcript

With us are Ken Mills, REGENXBIO's President and Chief Executive Officer, Dr. Steve Pakola, our Chief Medical Officer, Dr. Olivier Danos our Chief Scientific Officer, and Vit Vasista, our Chief Financial Officer. Earlier this afternoon, REGENXBIO released financial and operating results for the fourth quarter and full year ended December 31, 2020.